Close

Clovis (CLVS) options active on FDA accepts rucaparib NDA for priority review

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/18/2024

1. UAL
2. JBHT
3. TSLA
4. SAGE
5. TRV
6. ASML
7. PLD
8. SLG
9. OMC
10. IBKR


Go back to Clovis (CLVS) options active on FDA accepts rucaparib NDA for priority review
CLOVIS ONCOLOGY (NASDAQ: CLVS) Delayed: 0.08 --0 (-0%)
Previous Close $0.08    52 Week High $40.29 
Open $0.08    52 Week Low $11.57 
Day High $0.08    P/E N/A 
Day Low $0.08    EPS $-2.82 
Volume 45